populations and suggest that HP may be a very prevalent ILD in Portugal. Population-based studies and registries are urgently needed in order to properly understand the epidemiology of ILD in Portugal.
6. Hetzel J, Maldonado F, Ravaglia C, Wells AU, Colby TV, Tomassetti S, et al. 2 Estimates show that women have a higher incidence in the age group above 65 years, increasing the prevalence after menopause, while in men it occurs between 45 and 64 years of age. 3 Community based studies have shown that the male to female ratio is in the range of 2:1 to 4:1.
3 Differences in symptoms between men and women, particularly the reluctance of women to acknowledge OSA symptoms, contribute to the lower diagnosis in women. 4 Hormones are implicated in some gender-related variations, with differences between men and women decreasing as age increases. 5 Research has also documented gender differences in the structure and physiological behavior of the upper airway, in craniofacial morphology, in the pattern of fat deposition and respiratory stability. 6 In regard to polysomnography parameters, women tend to have less severe OSA, with a lower apnea-hypopnea index (AHI) and shorter apneas. 7 Episodes of upper airway resistance and flow limitation that do not meet the criteria for apneas are more common in women.
Therefore, the importance of OSA in women is increasingly being recognized, along with a number of significant gender-related differences in the symptoms, diagnosis, consequences and treatment of OSA.
We here present a prospective analysis which included all men and women with clinically suspected OSA, aged 30---50 years, diagnosed using conventional polysomnography (PSG) in our sleep unit throughout one year (2017 Table 1 . In this context, it is important to understand why men and women experience different AOS-related symptoms. Snoring is the most sensitive and strongest predictor of OSA in both genders. Although we did not obtain statistically significant differences, our results also show that snoring is more frequent in men than in women. We think that snoring and witnessed sleep apnea is underreported by women because it is still socially unacceptable. The fact that events in women are less exuberant, with a lower AHI, shorter apneas, less severe OSA, and more episodes of upper airway resistance and flow limitation which do not meet the criteria for apneas, also may have contributed to these results. Several studies have investigated the association of OSA with depression and anxiety. However, the relationship is still poorly understood. In our study we think that the depressive symptoms maybe more related to insomnia, excessive daytime sleepiness and disturbed unrefreshing sleep than to nocturnal hypoxemia. It may explain why women are more likely to have depressive syndrome. We did not find any differences in co-morbidities and current medications. Moreover, in women, it is essential to treat Table 2 . An important reported parameter is wake after sleep onset, also known as ''WASO''. This refers to periods of wakefulness occurring after defined sleep onset and it is a reflection of sleep fragmentation. This parameter measures wakefulness, excluding the wakefulness occurring before sleep onset and it can justify the fact that women complain more of initial insomnia and WASO is not different.
In conclusion, a growing evidence suggests that there are substantial differences between females and males in the symptoms, diagnosis and consequences of OSA. Our study shows statistical significant differences between genders in both clinical and polysomnographic parameters. Initial insomnia, depression, disturbed unrefreshing sleep, morning headache and higher Respiratory Effort Related Arousals index were noted in women. Men have more frequent witnessed sleep apnea as well as higher apnea, hypopnea and total RDI values. Better knowledge of gender differences in OSA will help to improve the awareness and diagnosis of OSA in women. The development and availability of therapeutic options that take into account these differences, could have the potential to improve outcomes for patients.
